Cytogenetic analysis ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 285 | ファンコニ貧血 | 1 |
285. ファンコニ貧血
臨床試験数 : 62 / 薬物数 : 93 - (DrugBank : 30) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 144
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00899795 (ClinicalTrials.gov) | June 2002 | 9/5/2009 | Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers | Stromal Injury and Clonal Adaptation in Myelodysplasia | Leukemia;Myelodysplastic Syndromes | Genetic: cytogenetic analysis;Genetic: fluorescence in situ hybridization;Other: flow cytometry;Procedure: biopsy | OHSU Knight Cancer Institute | National Cancer Institute (NCI) | Completed | 5 Years | 120 Years | All | 35 | N/A | United States |